Thirty-three percent of people on anticoagulants take OTC supplements with potentially serious interactions

supplements
Credit: CC0 Public Domain

Nearly 98% percent of people prescribed direct-acting oral anticoagulants such as apixaban used over-the-counter products. Of those, 33% took at least one such product that, in combination with the anticoagulants, could cause dangerous internal bleeding. People on these medications largely lacked knowledge of some potentially serious interactions.

Direct-acting are the drug of choice for stroke prevention in patients with , which occurs most frequently in . Apixaban is one of the most frequently prescribed. However, most people prescribed apixaban or other direct-acting oral anticoagulants are not followed in specialized anticoagulation clinics or monthly by health care professionals. As a result, these people may not be aware of potential drug interactions.

The researchers surveyed 791 English- and Spanish-speaking patients from April to October 2018 who had been prescribed apixaban about their knowledge of potential interactions between the drug and over-the-counter supplements. They were asked about how often they took aspirin, ibuprofen/naproxen, and acetaminophen, and 13 common dietary supplements, including Chinese herbs, various fish oils, ginger and herbal teas, while also taking apixaban.

Limitations to the study included a low response rate (33%), self-reported data, which can be unreliable due to faulty memories, and the researchers focused on a limited number of dietary supplements.

Because such a large number of people lack knowledge of these interactions, there is a need to educate patients and about the dangers that these combinations may pose. In addition, data are needed on outcomes in people combining apixaban and over-the-counter products.

The study is published in the Journal of the American Geriatrics Society.

Citation: Thirty-three percent of people on anticoagulants take OTC supplements with potentially serious interactions (2019, October 28) retrieved 24 April 2024 from https://medicalxpress.com/news/2019-10-thirty-three-percent-people-anticoagulants-otc.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New anti-clotting drugs linked to lower risk of serious bleeding

3 shares

Feedback to editors